THANK YOU TO OUR 2018 SPONSORS!

The abstracts in the Muscle and Nerve can be found
https://onlinelibrary.wiley.com/toc/10974598/2018/58/S1

The 2015 the Muscle Study Group Annual Meeting took place at its new home in Snowbird, UT at the Snowbird Ski & Summer Resort.

This year’s meeting, titled “Experimental Therapeutics Across the Spectrum of Neuromuscular Disease” was a huge success and brought together members from all across the globe, including pharmaceutical industry, NIH and academic researchers.

Final Agenda

2015 MSG Meeting Final Agenda

Abstracts

Meeting abstracts were published in Muscle & Nerve 2015; 52:S1 (September 2015)

Presentations

The Muscle Study Group has received approval from the authors to publish the following presentations on our website:

An Ounce of Prevention is Worth a Pound of Cure; Michael P. McDermott, PhD

NINDS Funding Opportunities; Glen Nuckolls, PhD

Placebo, History and Impact on Clinical Trials Outcome; Aziz Shaibani, M.D.

Best Practices for Preclinical Research in Neuroscience; Oswald Steward, PhD

Cost of Drugs for Neuromuscular Disorders; Donald B. Sanders, M.D.

Clinical Trials Programs at NIAMS; Tom Cheever, PhD

Sponsors 

The Muscle Study Group wishes to thank the sponsors of the 2015 annual meeting:

The 2014 Muscle Study Group Meeting took place at the Beaver Hollow Conference Center (Java Center, NY) – September

The meeting, titled “Economic Considerations in the Development of New Treatments for Neuromuscular Diseases” brought together members of the pharmaceutical industry, NIH and academic researchers.

Final Agenda

2014 MSG Meeting Final Agenda

Abstracts

Meeting abstracts were published in Muscle and Nerve 2014;50:S1 (September 2014)

Presentations

The Muscle Study Group has received approval from the authors to publish the following presentations on our website.

Transcriptome Profiling Identifies Key Differences Between Patients with Recessive or Dominant Negative Mutations in Collagen VI Related Myopathies – Russell Butterfield

Complications of Pregnancy in Myotonic Dystrophy – Nicholas Johnson

Funding New Investigators: The Role of the CTSAs – Karl Kieburtz

Targeting Mitochondrial Free Radical Production in Aging Skeletal Muscle – David Marcinek

Outcomes: MDA-NINDS Workshop – John Porter

Cataloging FDA’s Flexibility in Subpart H and Orphan Drug Approvals – Frank Sasinowski

Patient-Reported Outcomes (PROs) in Randomized Clinical Trials (RCTs) – Ira Shoulson

MRI in Experimental Muscle Therapeutics – Tracey Willis

Sponsors

The Muscle Study Group wishes to thank the sponsors of the 2014 annual meeting:

The 2013 Muscle Study Group Meeting was held at Lady Margaret Hall, Norham Gardens, Oxford, UK – September 16, 17 and 18.

The meeting was entitled “Novel Molecular Mechanisms of Neuromuscular Disease: Implications for Therapy” and brought together members of the pharmaceutical industry, NIH, FDA and academic researchers.

Final Agenda

2013 MSG Annual Meeting Final Agenda

Abstracts

Meeting abstracts were published in Muscle and Nerve 2013; 48:S1 (September 2013)

Sponsors

The Muscle Study Group wishes to thank the following for their support of the 2013 meeting: